Compounded drugs are not FDA-approved, so the FDA does not review the drugs safety, effectiveness, or quality before they are marketed
"Wegovy in a pill may also address patient preference for oral treatment," said Martin Holst Lange, chief scientific officer and executive vice president of research and development at Novo Nordisk, in the release
References Zanker J, Sim M, Anderson K, Balogun S, Brennan-Olsen SL, Dent E, Duque G, Girgis CM, Grossmann M, Hayes A, Henwood T, Hirani V, Inderjeeth C, Iuliano S, Keogh J, Lewis JR, Lynch GS, Pasco JA, Phu S, Reijnierse EM, Russell N, Vlietstra L, Visvanathan R, Walker T, Waters DL, Yu S, Maier AB, Daly RM, Scott D
The way a program handles dose increases, side effects, and follow-up support can shape how manageable treatment feels over time
The availability of those amino acids, especially cysteine, has long been observed as the rate-limiting variable in cellular synthesis
Durn, J